Assembly Biosciences Inc (ASMB)
17.49
+0.34
(+1.98%)
USD |
NASDAQ |
Jan 03, 16:00
17.56
+0.07
(+0.40%)
After-Hours: 20:00
Assembly Biosciences Research and Development Expense (Annual): 48.90M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Gilead Sciences Inc | 5.718B |
Protagonist Therapeutics Inc | 120.16M |
Precision BioSciences Inc | 53.38M |
RAPT Therapeutics Inc | 101.00M |
Entrada Therapeutics Inc | 99.88M |